Podchaser Logo
Home
Eyetube Podcasts

Bryn Mawr Communications

Eyetube Podcasts

A daily Science, Medicine and Technology podcast
Good podcast? Give it some love!
Eyetube Podcasts

Bryn Mawr Communications

Eyetube Podcasts

Episodes
Eyetube Podcasts

Bryn Mawr Communications

Eyetube Podcasts

A daily Science, Medicine and Technology podcast
Good podcast? Give it some love!
Rate Podcast

Episodes of Eyetube Podcasts

Mark All
Search Episodes...
DRCR Retina Network Protocol AB compared aflibercept (Eylea, Regeneron) to PPV and PRP in patients with diabetic vitreous hemorrhage. DRCR Retina Network Vice Chair and Protocol AB chair Andrew Antoszyk, MD, joins NRR to review the study's find
In this month's business-focused episode, Melanie Denton Dombrowski, OD, MBA, FAAO, shares her first-hand experience on opening a practice cold (00:52), then Jessilin Quint, OD, MBA, MS, provides five tactics to sustain a practice's growth, suc
Tracking real-world data on geographic atrophy has been patchwork process–until now. Thanks to the AAO IRIS Registry, real-world information on eye diseases can be gathered and assessed. What was found in the IRIS Registry regarding GA, and how
Settle in and listen to glaucoma specialist Lorraine Provencher, MD, and retina specialists Avni P. Finn, MD, MBA, and Christina Y. Weng, MD, MBA, navigate glaucoma and retina surgery for the cataract surgeon. These experts shed some light on p
In 2021, E/M codes will undergo their most significant changes since 1997. How will these changes affect your billing and coding-and what processes can you put in place to get ahead of the game? AAO Coding and Practice Management Executive Joy
The next generation of therapy for DME patients will require looking beyond the VEGF pathway. In the phase 2 BOULEVARD study, researchers are assessing the safety and efficacy of the angiopoietin-2 mediator faricimab (Roche/Genentech) for the t
In this special Thanksgiving episode of Ophthalmology Off the Grid, host Blake Williamson, MD, MPH, invites his colleagues to join him in expressing their gratitude. Hear from Dr. Williamson; Richard L. Lindstrom, MD; Evan Schoenberg, MD; Iqbal
Gerami Seitzman, MD, Medical Director of the Francis I. Proctor Foundation at the University of California, San Francisco, shares how she and her colleagues developed a drive-through IOP screening service for patients whose care was interrupted
In this podcast episode, Karolinne Rocha, MD, PhD*, and Elizabeth Yeu, MD, discuss the field of ocular biometry, including useful IOL power calculation formulas, as well as considerations taken for post-LASIK eyes and patients with astigmatism.
Retinal arteriolar macroaneurysm (RAM) usually regresses spontaneously, but can lead to irreversible vision loss if regression does not occur. Could anti-VEGF therapy be an option for these patients? J. Fernando Arevalo, MD, PhD, joins NRR to d
In this episode of the Survive & Thrive series, Gary Wörtz, MD, is joined by Nandini Venkateswaran, MD; Dagny Zhu, MD; and guest Preeya Gupta, MD, to talk about one of the big decisions faced by young ophthalmologists: private practice or acade
The burden of anti-VEGF therapy is particularly high in DME patients, many of whom are young, in the workforce, and unable to easily maintain monthly therapy. Could the antibody biopolymer conjugate KSI-301 (Kodiak Sciences) alleviate that burd
NRR's miniseries "The Art of Drug Choice: Wet AMD and the Latest Data" wraps up with moderator Dr. Khanani and panelists Drs. Fuller, London, and Weng discussing safety data. How have safety considerations changed in the wet AMD treatment lands
This NRR miniseries "The Art of Drug Choice: Wet AMD and the Latest Data" continues as Dr. Khanani and the roundtable participants Drs. Fuller, London, and Weng review the wet AMD pipeline with a focus on anti-Ang-2 therapy (faricimab, Roche/Ge
In episode 2 of the NRR miniseries "The Art of Drug Choice: Wet AMD and the Latest Data," Dr. Khanani and roundtable participants Drs. Fuller, London, and Weng review the latest phase 3 efficacy data from the HAWK/HARRIER, ARCHWAY, and CEDAR/SE
Arshad M. Khanani, MD, MA, leads a roundtable consisting of Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA, as they discuss the art of drug choice in wet AMD therapy. The panel discusses how and why the
No matter how hard you may try to rehabilitate the ocular surface of your dry eye patients, if you don't get good at-home regimens in place, they may fail treatment. In this episode of To the Point, Leslie and Jackie review the three categories
The Port Delivery System With Ranibizumab (Genentech) is under investigation for the treatment of wet AMD in the phase 3 ARCHWAY trial, data from which was shared at this year's AAO Annual Meeting. Nancy Holekamp, MD, sits down with NRR to prov
In this podcast episode, Steven J. Dell, MD*, reviews how the addition of the TECNIS® Multifocal Toric II IOL to the TECNIS® II Platform (Johnson & Johnson Vision) compares to the original lenses.*Steven J. Dell, MD is a paid consultant of John
Dr. Melissa Barnett and Dr. Tom Arnold talk with guest César Lipener, MD, from São Paulo, Brazil, about his journey of becoming a corneal surgeon and a contact lens specialist. Dr. Lipener shares advice and provides insights on fitting scleral
Lisa Nijm, MD, JD, Founder and Medical Director of Warrenville EyeCare and LASIK, in Warrenville, Illinois, shares her top 12 tips for elevating the quality of your online presentations, as featured in the September/October 2020 issue of Glauco
David Goldman, MD; Alice Epitropoulos, MD; Scott Schacter, OD; and Mary Pat Johnson discuss what factors will continue to shape the future of telemedicine in the post-COVID-19 era.
David Goldman, MD, and a faculty panel including Alice Epitropoulos, MD; Scott Schacter, OD; and Mary Pat Johnson share their pearls on telemedicine efficiency, including the best technologies and their most appropriate applications.
David Goldman, MD, leads a faculty panel including Alice Epitropoulos, MD; Scott Schacter, OD; and Mary Pat Johnson discussing how the COVID-19 pandemic has impacted the billing structure of telemedicine to be much more practice-friendly.
New Retina Radio's John Kitchens, MD, and Jorge Fortun, MD, introduce the premier episode of New Retina Radio Journal Club, a new series dedicated to reviewing the latest papers and how they relate to day to day clinical practice. In this episo
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features